Colorectal Cancer

Approximately 20% of patients who received discordant results for separate fecal immunochemical tests were later diagnosed with advanced neoplasia, according to study results.

Screening rates for colorectal cancer have increased over the last decade, according to data published in Clinical Gastroenterology and Hepatology. However, researchers found that despite this uptick, disparities in screening rates persist among racial and ethnic minority groups.

Patients with first-degree family members who have been diagnosed with colorectal cancer are at lower risk than previously estimated for developing the disease themselves, according to recent study results.

Cologuard, a non-invasive colorectal cancer screening test, has been approved for use in at-risk patients aged 45 and older.

Despite an increase in unplanned hospitalizations, colonoscopy is not associated with any increase in mortality as a colorectal cancer screening intervention, according to study results.

Recently published studies have demonstrated new developments in gastrointestinal cancer.

Health policy changes and a concerted, national effort have led to an overall increase in rates of colorectal cancer screening in the last decade. However, racial and ethnic disparities have persisted, according to study results. “While an overall improvement in screening rates should be acknowledged, our findings demonstrate that not all racial/ethnic groups benefited equally over time,” Folasade (Fola) P. May, MD, PhD, of the Tamar and Vatche Manoukin Division of Digestive Diseases at UCLA, and colleagues wrote. “Further, there are some groups, namely blacks and [American Indian or Alaska Natives], where improvements in screening disparities have stalled.”

Study results recently showed an increasing incidence of colorectal cancer among young adults in nine high-income countries. Also, the European Commission approved the expanded use of Stelara for adults with moderately to severely active ulcerative colitis.

Researchers from the American Cancer Society have found increasing incidence of colorectal cancer among young adults in nine high-income countries where population-based screening initiatives have led to stabilized or decreasing trends among older adults, according to study results published in Gut.

Nonalcoholic fatty liver disease correlated with an approximately 90% higher risk for liver and gastrointestinal cancers compared with patients without fatty liver disease, while the association between obesity without fatty liver disease and cancer was small.